Drugs: Piqray details - Forms, strengths, administration, and additional info
In the realm of medical advancements, a new prescription medication named Piqray (alpelisib) has emerged as a potential long-term treatment for specific types of advanced or metastatic breast cancer. This drug belongs to a class of kinase inhibitors and, unlike many other medications, does not have a generic version.
Piqray is intended for use in combination with fulvestrant, and it's primarily prescribed for postmenopausal women and men who have HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer. The treatment is given continuously on a 28-day cycle.
Piqray comes in the form of oral tablets, available in three strengths: 50 mg, 150 mg, and 200 mg. The recommended dosage for treating metastatic breast cancer is 300 mg taken orally once daily with food. This dose can be achieved by taking a combination of tablets, such as one 250 mg and one 50 mg tablet.
To ensure optimal absorption and reduce gastrointestinal side effects, Piqray should be taken with food. It's crucial to follow the dosage prescribed by your doctor and not change your dose or stop taking Piqray unless recommended by your healthcare provider.
Piqray tablets should not be crushed, cut, chewed, or split. If a tablet appears cracked, broken, or damaged, it should not be swallowed. In such cases, contact your pharmacist for guidance.
As with any medication, Piqray can cause side effects. Monitoring for hyperglycemia, rash, diarrhea, and pneumonitis is essential, as these are notable side effects. Dose modifications or interruptions may be required for adverse reactions.
If you miss a dose of Piqray by more than 9 hours, skip that day's dose and take your usual dose the next day at your regular time. Never take a double dose to make up for a missed dose.
It's essential to consult your healthcare provider for individual patient guidance regarding Piqray. If you believe you've taken too much Piqray, call your doctor right away or contact the American Association of Poison Control Centers.
Symptoms of a Piqray overdose can include hyperglycemia (high blood sugar), nausea, weakness, skin rash, increased thirst, intense hunger, blurred vision, weight loss, and irritability.
In conclusion, Piqray offers a new treatment option for individuals battling advanced or metastatic breast cancer. As with all medications, it's crucial to follow the dosage prescribed by your doctor and to be aware of potential side effects. Always consult your healthcare provider for individual patient guidance.
- Piqray, a new medication, is a potential long-term treatment for specific types of advanced or metastatic breast cancer, particularly for postmenopausal women and men with HR-positive, HER2-negative, PIK3CA-mutated breast cancer.
- The drug belongs to a class of kinase inhibitors and does not have a generic version, making it unique among many other medications.
- Piqray comes in the form of oral tablets, available in three strengths: 50 mg, 150 mg, and 200 mg, with a recommended dosage of 300 mg taken orally once daily with food.
- To reduce gastrointestinal side effects, Piqray should be taken with food, and it's crucial to follow the dosage prescribed by the doctor, as changing your dose or stopping the medication should only be done as recommended by your healthcare provider.
- Monitoring for hyperglycemia, rash, diarrhea, and pneumonitis is essential, as these are notable side effects, and dose modifications or interruptions may be required for adverse reactions.
- In the realm of health and wellness, men's health, women's health, and oncology, Piqray is a significant medical advancement, offering a new treatment option for individuals battling advanced or metastatic breast cancer, but it's essential to consult your healthcare provider for individual patient guidance.
